Browse

Deep Tumor Penetration of Drug-Loaded Nanoparticles by Click Reaction-Assisted Immune Cell Targeting Strategy

DC Field Value Language
dc.contributor.authorLee, Soo Hong-
dc.contributor.authorPark, Ok Kyu-
dc.contributor.authorKim, Jonghoon-
dc.contributor.authorShin, Kwangsoo-
dc.contributor.authorPack, Chan Gi-
dc.contributor.authorKim, Kang-
dc.contributor.authorKo, Giho-
dc.contributor.authorLee, Nohyun-
dc.contributor.authorKwon, Seung-Hae-
dc.contributor.authorHyeon, Taeghwan-
dc.date.accessioned2020-04-27T13:20:57Z-
dc.date.available2020-04-27T13:20:57Z-
dc.date.issued2019-09-
dc.identifier.citationJournal of the American Chemical Society, Vol.141 No.35, pp.13829-13840-
dc.identifier.issn0002-7863-
dc.identifier.other87218-
dc.identifier.urihttp://hdl.handle.net/10371/165791-
dc.description.abstractNanoparticles have been extensively used to deliver therapeutic drugs to tumor tissues through the extravasation of a leaky vessel via enhanced permeation and retention effect (EPR, passive targeting) or targeted interaction of tumor-specific ligands (active targeting). However, the therapeutic efficacy of drug-loaded nano particles is hampered by its heterogeneous distribution owing to limited penetration in tumor tissue. Inspired by the fact that cancer cells can recruit inflammatory immune cells to support their survival, we developed a click reaction assisted immune cell targeting (CRAIT) strategy to deliver drug-loaded nanoparticles deep into the avascular regions of the tumor. Immune cell-targeting CD11b antibodies are modified with trans-cyclooctene to enable bioorthogonal click chemistry with mesoporous silica nanoparticles fiinctionalized with tetrazines (MSNs-Tz). Sequential injection of modified antibodies and MSNs-Tz at intervals of 24 h results in targeted conjugation of the nanoparticles onto CD11b(+) myeloid cells, which serve as active vectors into tumor interiors. We show that the CRAIT strategy allows the deep tumor penetration of drug-loaded nanoparticles, resulting in enhanced therapeutic efficacy in an orthotopic 4T1 breast tumor model. The CRAIT strategy does not require ex vivo manipulation of cells and can be applied to various types of cells and nanovehicles.-
dc.titleDeep Tumor Penetration of Drug-Loaded Nanoparticles by Click Reaction-Assisted Immune Cell Targeting Strategy-
dc.typeArticle-
dc.contributor.AlternativeAuthor현택환-
dc.identifier.doi10.1021/jacs.9b04621-
dc.citation.journaltitleJournal of the American Chemical Society-
dc.identifier.scopusid2-s2.0-85071787754-
dc.citation.endpage13840-
dc.citation.number35-
dc.citation.startpage13829-
dc.citation.volume141-
dc.identifier.urlhttps://pubs.acs.org/doi/10.1021/jacs.9b04621-
dc.identifier.rimsid87218-
dc.identifier.sci000484828900024-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorHyeon, Taeghwan-
Appears in Collections:
College of Engineering/Engineering Practice School (공과대학/대학원)Dept. of Chemical and Biological Engineering (화학생물공학부)Chemical Convergence for Energy and Environment (에너지환경 화학융합기술전공)Journal Papers (저널논문_에너지환경 화학융합기술전공)
College of Engineering/Engineering Practice School (공과대학/대학원)Dept. of Chemical and Biological Engineering (화학생물공학부)Journal Papers (저널논문_화학생물공학부)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse